Lessons learnt from ceftriaxone-resistant gonorrhoea in the UK and Australia
- 1 March 2020
- journal article
- editorial
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 20 (3), 276-278
- https://doi.org/10.1016/s1473-3099(20)30055-4
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018Eurosurveillance, 2019
- Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018Eurosurveillance, 2019
- Direct Detection of penA Gene Associated with Ceftriaxone-Resistant Neisseria gonorrhoeae FC428 Strain by Using PCREmerging Infectious Diseases, 2018
- Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018Eurosurveillance, 2018
- Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae StrainEmerging Infectious Diseases, 2018
- Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative actionPLoS Medicine, 2017
- Failure of Dual Antimicrobial Therapy in Treatment of GonorrheaThe New England Journal of Medicine, 2016
- Isolated pharyngeal Neisseria gonorrhoeae in heterosexual male contactsInternational Journal of STD & AIDS, 2013
- In Vitro Activity of Ertapenem versus Ceftriaxone against Neisseria gonorrhoeae Isolates with Highly Diverse Ceftriaxone MIC Values and Effects of Ceftriaxone Resistance Determinants: Ertapenem for Treatment of Gonorrhea?Antimicrobial Agents and Chemotherapy, 2012